The majority of these studies showed that the expression of lumican was abnormal; the cancer types studied included gastric cancer, colorectal cancer, pancreatic cancer, breast cancer, malignant melanoma, and other malignant tumor tissues. Here, LUM is linked to pancreatic neoplasm.